Medical Director/Investigator Clinical Neuroscience Solutions, Inc. 207 West Gore Street, Suite 200 Orlando, Fl 32806 01/00 - present
Investigator on over 280 phase I-IV clinical trials in children, adolescents,
Diagnoses include: Fibromyalgia, Sleep Disorders, Pain, Smoking Cessation, Alcohol Dependence, Migraine, Alzheimer’s disease, Rheumatoid Disorders, Skin Disorders, Women’s Health, Attention-deficit hyperactivity disorder, Autism, Mood disorders, Obesity, Chemical Dependency, Dementias, Diabetes, Diabetic peripheral neuropathy, Diverticulitis, Epilepsy, Fatigue, Female Sexual Arousal Disorder, Gambling Cessation, Generalized anxiety, Gout, Hot flashes, Hypertension, Hyposexual Arousal Disorder, Irritable Bowel Syndrome, Lower back pain, Menstrual migraine, Mild Cognitive Impairment, Obsessive-compulsive disorder, Oppositional defiant disorder, Panic disorder, Post-herpetic Neuralgia, Post-traumatic stress disorder, Schizophrenia, Sexual dysfunction, Social phobia, Stuttering and Vulvar & Vaginal Atrophy.
Private Practice, Orlando, Florida and Kissimmee, Florida;
1987 – 2004 Consulting Physician, Orlando Regional Medical Center, Orlando & Longwood, Florida; 1988 – 2005 Consulting Physician, Florida Hospital, Orlando, Florida; 1989 – 2001 Medical Director & Medical Monitor, Charter Health System, Clinical Trials Program, Kissimmee, Florida; 1997 – 1999 Director of Addictions Unit, Florida Hospital, Orlando, Florida; 1987 – 1988 Staff Physician, Emergency Medicine, Emergency Room; Multiple Hospitals in GA and FL; 1984 – 1986
Intern, Memorial Medical Center, Department of Internal Medicine,
CNS Healthcare Orlando ● 207 West Gore Street, Suite 200 ● Orlando, FL 32806
2003 Clinical Neuroscience Solutions, Inc,.
Intern and Resident, Medical College of Georgia, Department of Psychiatry, Augusta, GA; 1982 - 1984; 1985 -1986
Resident, University of South Florida College of Medicine, Geriatric Fellowship, Tampa, FL; 1986 - 1987
CEBU Doctor’s College of Medicine Doctor of Medicine; 1978 – 1982 University of Central Florida, Orlando, Florida Bachelor of Arts, Psychology and Bachelor of Science, Biology; 1972 – 1976
Florida Medical License Number: ME 47298
Harper, L., Schmechel, D., Gerard, G., Vatakis, N., Ross, J.S., Bari, M.,
Walling, D., Stedman, M., Winston, J., Morimoto, B., and Keith, J.: A Phase 2, Double- Blind, Placebo-Controlled Study to Evaluate the
Safety, Tolerability, and Effect on Cognitive Function of AL-108 after 12 Weeks of Intranasal Administration in Subjects with Mild Cognitive Impairment. 2008. Childress, A., Muniz, R., Harper, L., Miller, J., Arnold, V., Gerstner, O., Borello, M., Thulasiraman, A., Post, A.: A Fixed-Dose Titration Study of Desmethylphenidate Extended Release in Children with ADHD, New Research Poster, AACAP.
Maurizio Fava, David Mischoulon, Dan Iosifescu, Janet Witte, Michael Pencina, Martina Flynn, Linda Harper, Michael Levy, Karl Rickels, Mark Pollack: A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy (ADT) Among Depressed Outpatients with Inadequate Response to Prior ADT (ADAPT-A Study). 2009.
Professional Poster Hunter, B.D., Brown, P.W., Angel, S., Carmichael, L., Harper, L.S.,
Joyce, J.M., & McGill, L.J. The Impact of Patient Recruitment Methods on Data Quality. New Clinical Drug Evaluation Unit (NCDEU) Meeting, Phoenix, AZ, June 2012.
Abbott Laboratories, Addrenex, Alkermes, Allergan, Allon, Alza, AstraZeneca, Avera, Boehringer-Ingelheim, Biovail Laboratories, Bristol-Myers Squibb, CeNeRx, Cephalon, Celltech, Collegium, Covidien, Cubist, Depomed, DOV, Endo Pharmaceuticals, Eisai, Eli Lilly, Euthymics, Forest, Fujisawa, Furiex, GlaxoSmithKline, Grunenthal, Indevus/Endo, Janssen, Jazz, Johnson & Johnson, Labopharm, Lundbeck, Mass General Hospital, Merck, Mitsubishi, Myriad, Neurosearch, New River Pharmaceuticals, Novartis, ONO, Organon, Ortho-McNeil, Otsuka, Palatin Technologies, Pfizer, PGxHealth,
CNS Healthcare Orlando ● 207 West Gore Street, Suite 200 ● Orlando, FL 32806
2003 Clinical Neuroscience Solutions, Inc,.
Repligen, Saegis, Sanofi, Sepracor, Shionogi, Shire, SmithKline Beecham, Solvay, Somaxon, Supernus, Synosia, Takeda, Targacept, Transtech, Vanda, and Wyeth.
CNS Healthcare Orlando ● 207 West Gore Street, Suite 200 ● Orlando, FL 32806
2003 Clinical Neuroscience Solutions, Inc,.
Nottingham Traffic Lights System of Prescribing DEVELOPMENT This document is now maintained and updated by the Nottingham Area Prescribing Committee (APC). The APC includes representatives from all three hospital trusts (Chair and Secretary of Drug and Therapeutics Committee), all of the Nottingham PCTs (GP prescribing lead, prescribing advisers, nurse lead), LMC and LPC. OBJECTIVE
Deworming and schooling Beyond their direct health and nutrition impacts, worm infections can also affect children’s schooling Anemia, lethargy and weakness make attending school and learning difficultThis is a critical channel from the point of view of economic development: schooling leads to greater productivity and Schooling impacts would provide a further public policy rationale